May 13, 2021
Highlights: New England Journal of Medicine publishes exploratory study showing signals of positive activity i...
May 6, 2021
London, UK, May 06, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company...
April 29, 2021
London, UK, 30 April 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a menta...
April 27, 2021
London, UK , April 27, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental heal...
April 15, 2021
Study concludes that psilocybin findings should be explored further in larger studies London, UK, April 15, 20...
April 9, 2021
London, UK , April 09, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care comp...
April 1, 2021
COMPASS Pathways appoints Wayne J Riley MD to its Board of Directors London, UK – 1 April 2021 COMPASS...
March 23, 2021
COMPASS Pathways granted two US patents London, UK – 23 March 2021 COMPASS Pathways plc (Nasdaq: CMPS) (“C...
March 9, 2021
Highlights include continued progress with phase IIb psilocybin therapy clinical trial, launch of first Centre...
March 2, 2021
New York, March 02, 2021 (GLOBE NEWSWIRE) -- London, UK – 2 March 2021 COMPASS Pathways plc (Nasdaq: CMPS), ...
